Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- ChecktodayChange DetectedA new revision tag was added (v3.7.0) and several related-topic entries were removed, indicating housekeeping updates to the page's metadata and topics.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLung cancer is added as a MeSH term and a Related topics section now includes a MedlinePlus Genetics link. The revision label was updated to v3.6.6 from v3.6.5.SummaryDifference0.1%

- Check21 days agoChange DetectedThe addition '2015 ( U.S. NIH Grant/Contract )' was added to the Other Study ID Numbers to indicate NIH funding for the study.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating a new version tag. The older revision tag Revision: v3.6.4 and related topic items (Lung cancer, MedlinePlus Genetics) were removed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page gains new related-topic links for Lung cancer and MedlinePlus Genetics. These additions expand external resource connections.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small backend or formatting update to the page. No changes to the study details or visible content are introduced.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.